These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10634450)
21. The relationship between diffuse axonal damage and fatigue in multiple sclerosis. Tartaglia MC; Narayanan S; Francis SJ; Santos AC; De Stefano N; Lapierre Y; Arnold DL Arch Neurol; 2004 Feb; 61(2):201-7. PubMed ID: 14967766 [TBL] [Abstract][Full Text] [Related]
22. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. De Stefano N; Narayanan S; Francis SJ; Smith S; Mortilla M; Tartaglia MC; Bartolozzi ML; Guidi L; Federico A; Arnold DL Arch Neurol; 2002 Oct; 59(10):1565-71. PubMed ID: 12374493 [TBL] [Abstract][Full Text] [Related]
23. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. De Stefano N; Narayanan S; Matthews PM; Francis GS; Antel JP; Arnold DL Brain; 1999 Oct; 122 ( Pt 10)():1933-9. PubMed ID: 10506094 [TBL] [Abstract][Full Text] [Related]
24. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651 [TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance spectroscopy: imaging axonal damage in MS. Arnold DL J Neuroimmunol; 1999 Jul; 98(1):2-6. PubMed ID: 10426355 [TBL] [Abstract][Full Text] [Related]
26. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Reddy H; Narayanan S; Arnoutelis R; Jenkinson M; Antel J; Matthews PM; Arnold DL Brain; 2000 Nov; 123 ( Pt 11)():2314-20. PubMed ID: 11050031 [TBL] [Abstract][Full Text] [Related]
27. Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy. Wood ET; Ronen I; Techawiboonwong A; Jones CK; Barker PB; Calabresi P; Harrison D; Reich DS J Neurosci; 2012 May; 32(19):6665-9. PubMed ID: 22573688 [TBL] [Abstract][Full Text] [Related]
28. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience. He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260 [TBL] [Abstract][Full Text] [Related]
29. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis. Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798 [TBL] [Abstract][Full Text] [Related]
30. Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis. Sarchielli P; Presciutti O; Tarducci R; Gobbi G; Alberti A; Pelliccioli GP; Chiarini P; Gallai V J Neurol; 2002 Jul; 249(7):902-10. PubMed ID: 12140676 [TBL] [Abstract][Full Text] [Related]
31. Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis. Siger-Zajdel M; Selmaj KW J Neurol; 2005 Jul; 252(7):830-2. PubMed ID: 15772740 [TBL] [Abstract][Full Text] [Related]
33. [Total brain T2-hyperintense lesion-volume and the axonal damage in the normal-appearing white matter of brainstem in early lapsing-remitting multiple sclerosis]. Pascual-Lozano AM; Martínez-Bisbal MC; Boscá-Blasco I; Valero-Merino C; Coret-Ferrer F; Martí-Bonmatí L; Martínez-Granados B; Celda B; Casanova-Estruch B Rev Neurol; 2007 Oct 16-31; 45(8):468-73. PubMed ID: 17948212 [TBL] [Abstract][Full Text] [Related]
34. Relating MRI changes to motor deficit after ischemic stroke by segmentation of functional motor pathways. Pineiro R; Pendlebury ST; Smith S; Flitney D; Blamire AM; Styles P; Matthews PM Stroke; 2000 Mar; 31(3):672-9. PubMed ID: 10700503 [TBL] [Abstract][Full Text] [Related]
35. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. Stromillo ML; Giorgio A; Rossi F; Battaglini M; Hakiki B; Malentacchi G; Santangelo M; Gasperini C; Bartolozzi ML; Portaccio E; Amato MP; De Stefano N Neurology; 2013 Jun; 80(23):2090-4. PubMed ID: 23635962 [TBL] [Abstract][Full Text] [Related]
36. Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? Davie CA; Silver NC; Barker GJ; Tofts PS; Thompson AJ; McDonald WI; Miller DH J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):710-5. PubMed ID: 10567484 [TBL] [Abstract][Full Text] [Related]
37. Diffusion-weighted imaging of normal appearing corticospinal tracts in patients with multiple sclerosis. Yalçın-Şafak K; Akça A; Elibol Ö; Sarı İ Neuroradiol J; 2018 Apr; 31(2):142-146. PubMed ID: 29260606 [TBL] [Abstract][Full Text] [Related]
38. A study of multiple sclerosis patients with magnetic resonance spectroscopic imaging. Peters AR; Geelen JA; den Boer JA; Prevo RL; Minderhoud JM; 's Gravenmade EJ Mult Scler; 1995 Apr; 1(1):25-31. PubMed ID: 9345466 [TBL] [Abstract][Full Text] [Related]
39. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. Davie CA; Barker GJ; Thompson AJ; Tofts PS; McDonald WI; Miller DH J Neurol Neurosurg Psychiatry; 1997 Dec; 63(6):736-42. PubMed ID: 9416807 [TBL] [Abstract][Full Text] [Related]
40. Proton magnetic resonance spectroscopy of normal appearing white matter in asymptomatic relatives of multiple sclerosis patients. Siger-Zajdel M; Selmaj K Eur J Neurol; 2006 Mar; 13(3):296-8. PubMed ID: 16618349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]